EnlitenAI is an early stage startup based in Tracy, California that is building an AI-driven platform for neurological conditions aimed at better management and treatment of seizures and epilepsy. Their flagship product, NeuroLiten, is offered on the cloud as a SaaS subscription and is designed to be both scalable and extendable.
With epilepsy as their immediate focus, EnlitenAI is leveraging the specificity of the condition to build appropriate functionality and features into their platform. This can then be easily modified to expand their business into adjacent market segments for autism/ADD, behavioral and sleep disorders, Parkinson’s Disease, Alzheimer’s, and other neurological conditions.
NeuroLiten is a connected platform for personalized healthcare for neurological conditions, leveraging AI/data analytics and wearables/IoT. It is both mobile and web-enabled, providing patients and healthcare professionals with a seamless experience. EnlitenAI’s vision is to build an end-to-end platform that creates a novel healthcare delivery system by monitoring patient vital parameters using wearables and leveraging AI/analytics on context-rich data for personalized healthcare.
Revolutionizing Neurological Care with AI-driven Platform
EnlitenAI is making waves in the healthcare industry with their AI-driven platform for neurological conditions. With their focus on epilepsy, they are building a platform that will improve the management and treatment of the condition. Their platform is scalable and extendable, making it easy to expand into other neurological conditions.
Personalized Healthcare for Neurological Conditions
EnlitenAI’s NeuroLiten platform is a connected platform for personalized healthcare for neurological conditions. It leverages AI/data analytics and wearables/IoT to monitor patient vital parameters and provide personalized healthcare. With the platform being mobile and web-enabled, patients and healthcare professionals can access it from anywhere, making it a convenient solution for neurological care.
Building an End-to-End Platform
EnlitenAI’s NeuroLiten platform has the potential to change the way neurological conditions are managed and treated. With their focus on epilepsy and their scalable and extendable platform, EnlitenAI is poised to make a significant impact in the healthcare industry. Their vision of building an end-to-end platform for personalized healthcare is a game-changer and has the potential to improve the lives of millions of people around the world.
Ready to Promote Your Brand with Finance Magazine?
Looking to reach a targeted audience of finance professionals and decision-makers? Finance Magazine offers sponsored article opportunities and partnerships to help you showcase your brand and drive sales. Learn more about our advertising options and reach out to us today! Click here to discuss sponsored articles and partnerships.
Maximize your brand visibility and engage with a highly engaged finance audience. Contact us at [email protected] to get started. Let Finance Magazine be your platform for success!